Hyperphosphataseemia in children
Hyperphosphatamia in children is an autosomal recessive genetic disease, which is extremely rare. Most people believe that this disease is a bone tissue metabolic disorder, which is mainly manifested by excessive osteolysis and osteoblastic processes, resulting in incomplete ossification. The affected parts are commonly the skull, tibia, femur, spine, etc. Its characteristics are a significant increase in serum alkaline phosphatase, and normal serum calcium and phosphorus.
-
Site of disease:
bone -
Infectious :
Not contagious -
Frequent population:
2-3 years old -
Related symptoms:
Unsteady gait Increased alkaline phosphatase Bone pain Kyphosis Slow growth -
Concurrent disease:
Related Drugs
Compound Amino Acid Injection for Children (18AA-Ⅱ)
Indication: 1. Premature infants, low-birth-weight infants, and newborns who cannot orally take in protein or who do not take enough protein due to various causes. 2. Children with various injuries: such as burns, trauma, and postoperative high metabolic state. 3. Children with various acute or chronic malnutrition who cannot orally take in food or do not take enough food: such as necrotizing enterocolitis, acute necrotizing pancreatitis, chemotherapy drug reactions, etc.
Manufacturer:
Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd.
Children's Glufosinate Pantricalcium Tablets
Indication: No data yet
Manufacturer:
Jia Mu Si Luling Sunflower Pharmaceutical Group Co., Ltd.